A recent paper published in ScienceAdvances presents a novel deep learning approach to identify computational histopathological signatures that predict overall survival in high-grade gliomas (HGG)—a particularly aggressive type of brain tumor.
Study: Sexually dimorphic computational histopathological signatures prognostic of overall survival in high-grade gliomas via deep learning. Image Credit: Tomatheart/Shutterstock.com
This method focuses on the sex-specific features of the tumor microenvironment (TME), offering tailored risk profiles for male and female patients. By understanding these sex differences in tumor characteristics, researchers aim to improve personalized treatment strategies for HGG patients.
Advances in HGG Treatment
HGGs are extremely fatal tumors with very low survival rates (approx. 15 to 18 months), even with treatments like surgery, radiotherapy, and chemotherapy. These tumors mainly form in the brain or spinal cord and are among the most common forms of cancer in children. They grow and spread quickly throughout the nervous system, easily invading healthy cells.
Studies have shown that sex differences play a significant role in survival outcomes, with males generally having worse survival rates than females. These differences are linked to factors such as hormonal, metabolic, and immune responses, as well as sex-specific genetic changes and molecular subtypes.
Traditionally, neuropathologists examine hematoxylin and eosin (H&E) stained tissue slides, a time-consuming process that can vary between observers. However, advancements in computational tools and digitized slides have led to the development of deep learning-based pathomics methods, allowing for faster and more accurate analysis of tumor characteristics.
A Deep Learning Approach to Histopathology
In this study, the researchers used a deep learning framework to analyze H&E-stained tissue slides from surgically removed HGG tumors, focusing on identifying survival-related tumor features in a sex-specific manner. The study employed a two-stage process using ResNet18 models. In the first stage, the ResNet18 model segmented viable tumor regions. In the second stage, separate sex-specific models were trained to predict overall survival for male and female patients.
Data from 514 HGG patients were analyzed, and the models were validated across three independent cohorts. The research team used two convolutional neural networks (CNNs)—ResNetSeg-18 for segmenting tumor regions and ResNet-Cox, which incorporated survival prediction using Cox proportional hazards models.
Key Findings
The deep learning models demonstrated that sex-specific analysis outperformed general models in predicting survival outcomes for HGG patients. For male patients, high-risk areas were linked to features such as microvascular proliferation (MVP) and pseudopalisading cells, while for female patients, infiltrating tumors and MVP were associated with higher risk. Visual risk density maps generated from the models provided insight into the specific regions of the TME that contributed to survival risk predictions.
The male-specific ResNet-Cox model achieved a concordance index (C-index) of 0.712, while the female-specific model had a C-index of 0.673. These values remained consistent across validation cohorts, further confirming the robustness of the sex-specific models.
Enhancing Accuracy with Multimodal Data
In addition to histopathological features, the researchers incorporated clinical and molecular data—such as patient age, IDH mutation status, and MGMT promoter methylation—to improve the models' accuracy. This led to the development of multimodal ResNet-Cox models (mResNet-Cox), which performed even better in differentiating between high- and low-risk patients.
The models were evaluated using Kaplan-Meier curves and concordance indices, and visualization techniques such as t-SNE and UMAP were used to highlight key tumor features linked to survival outcomes.
Applications in Personalized Medicine
This research offers exciting prospects for the personalized treatment of HGG patients. By identifying sex-specific tumor characteristics, clinicians can create more tailored treatment plans, potentially improving survival outcomes. Deep learning-based histopathology analysis also speeds up the diagnostic process and reduces the variability associated with manual assessments.
Furthermore, integrating genomic biomarkers with histopathological data enhances the precision of these prognostic models, which could be extended to other cancers and diseases, making this approach highly valuable in the field of precision medicine.
Conclusion and Future Directions
In summary, this research demonstrates the potential of deep learning to uncover sex-specific histopathological features in high-grade gliomas, offering more accurate predictions of overall survival. The development of these prognostic models based on sex differences represents a major step toward personalized treatment strategies for HGG patients.
Moving forward, incorporating additional clinical and molecular data will likely improve the accuracy and effectiveness of these models. As research in this area progresses, deep learning could become an essential tool in the fight against not only gliomas but other complex cancers, providing more personalized and effective treatments.
Journal Reference
Verma, R., & et al. Sexually dimorphic computational histopathological signatures prognostic of overall survival in high-grade gliomas via deep learning. ScienceAdvances, 2024, 10, 34. DOI: 10.1126/sciadv.adi0302, https://www.science.org/doi/10.1126/sciadv.adi0302
Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.